Boston ScientificBSX
Market Cap: $123B
About: Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Employees: 48,000
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
113% more first-time investments, than exits
New positions opened: 168 | Existing positions closed: 79
33% more funds holding in top 10
Funds holding in top 10: 27 [Q1] → 36 (+9) [Q2]
33% more repeat investments, than reductions
Existing positions increased: 536 | Existing positions reduced: 404
12% more capital invested
Capital invested by funds: $90.6B [Q1] → $102B (+$11.2B) [Q2]
7% more funds holding
Funds holding: 1,190 [Q1] → 1,279 (+89) [Q2]
0.2% less ownership
Funds ownership: 90.22% [Q1] → 90.01% (-0.2%) [Q2]
3% less call options, than puts
Call options by funds: $728M | Put options by funds: $754M
Research analyst outlook
17 Wall Street Analysts provided 1 year price targets over the past 3 months
17 analyst ratings
Raymond James Jayson Bedford 61% 1-year accuracy 19 / 31 met price target | 13%upside $94 | Strong Buy Maintained | 4 Sept 2024 |
Citigroup Joanne Wuensch 70% 1-year accuracy 28 / 40 met price target | 10%upside $92 | Buy Maintained | 22 Aug 2024 |
Barclays Matt Miksic 71% 1-year accuracy 22 / 31 met price target | 3%upside $86 | Overweight Maintained | 22 Aug 2024 |
Raymond James Jayson Bedford 61% 1-year accuracy 19 / 31 met price target | 9%upside $91 | Strong Buy Maintained | 25 Jul 2024 |
Deutsche Bank Pito Chickering 82% 1-year accuracy 9 / 11 met price target | 6%downside $78 | Hold Maintained | 25 Jul 2024 |
Financial journalist opinion
Based on 15 articles about BSX published over the past 30 days